Where: The University of Pennsylvania, Philadelphia, PA USAWhy study at the Penn Ovarian Cancer Research Center?
The School is comprised of 28 basic and clinical department, with over 2,500 faculty members and more than 2,500 students and trainees. In fiscal year 2018, the School received $814 million in support of its research activities from extramural sponsors, including $424 million from the National
Institutes of Health, ranking 5th in the nation among all academic medical institutions.
The goal of the OCRC is to translate important biological principles discovered in the laboratory into clinically useful diagnostic and therapeutic tools. We achieve this goal through a multidisciplinary approach that spans efforts in immunology and immunotherapy, vascular biology, epigenetics,
genomics, early detection methods, and novel experimental model systems.
Philadelphia is a thriving, historic city. It is the birthplace of America, the home of Rocky, anda haven for sports fans and food lovers. The University of Pennsylvania is the oldest and>
biomedical research, and medical education.
Founded in 2007, the Penn Ovarian Cancer Research Center (OCRC) has been a leader in cutting-edge research
focused on gynecologic malignancies.
Position: The Drapkin laboratory is seeking fun, energetic, driven scientists to join our dynamic group and make a difference in ovarian cancer. The ideal candidate will be a highly motivated graduate student who is ready to advance into a postdoctoral position and make a 4-5 year commitment. Candidates will have a PhD in Biochemistry, Molecular Biology, Cell Biology, or related Biological Science and a strong publication record. The postdoc will be expected to work independently and should be facile with basic molecular biology techniques (tissue culture, DNA/RNA analyses, biochemistry, and rudimentary bioinformatics). The successful candidate must be well organized, fluent in English, be able to analyze data and results from experiments, be an independent thinker but also a team player.
Employer: Dr. Ronny Drapkin is the Director of the Penn OCRC and co-directs the Basser Center for BRCA. The Drapkin laboratory focuses>
Recent work from our group has implicated
genomic instability, DNA repair, replicative stress, and tumor metabolism.